Equities researchers at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report issued on Tuesday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens upped their price target on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, January 31st.
Get Our Latest Stock Analysis on MDRX
Veradigm Stock Up 4.8%
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- How to Invest in Biotech Stocks
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- Trading Stocks: RSI and Why it’s Useful
- What Ray Dalio’s Latest Moves Tell Investors
- What is a Bond Market Holiday? How to Invest and Trade
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.